Latest / Butte News Today | 2 Min News | The Daily News Now!
FDA Weighs Unapproved Peptides in Compounding Pharmacies | Butte News
The FDA is weighing whether compounding pharmacies should be allowed to make seven experimental peptides—ranging from pain relief to performance enhancement—despite a lack of solid human evidence proving their safety or effectiveness. With these unapproved substances circulating online, often promoted by influencers with vested interests, experts warn of dangerous gaps in oversight and unknown long-term risks. As demand grows and foreign-made drugs surge, the stakes are high: the FDA’s decision could reshape access, regulation, and public health—or leave consumers vulnerable to unproven…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.